CLVLF OTC
Clinuvel Pharmaceuticals Limited
1W: -3.6%
1M: -3.4%
3M: -6.9%
YTD: -26.2%
1Y: -28.1%
3Y: -39.2%
5Y: -80.8%
$5.68
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$296M
+8.8% ▲
5Y CAGR: +22.2%
Total Liabilities
$23M
-24.9% ▼
5Y CAGR: +18.8%
Shareholders Equity
$272M
+13.2% ▲
5Y CAGR: +22.5%
Cash & Investments
$252M
+12.3% ▲
5Y CAGR: +24.9%
Total Debt
$2M
+266.3% ▲
5Y CAGR: +8.2%
Net Debt
-$18M
+91.7% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $122M | $157M | $184M | $224M | $20M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $231M |
| Cash & ST Investments | $122M | $157M | $184M | $224M | $252M |
| Net Receivables | $16M | $22M | $26M | $27M | $23M |
| Inventory | $2M | $10M | $11M | $9M | $7M |
| Other Current Assets | $0 | $0 | $1M | $3M | $0 |
| Total Current Assets | $141M | $190M | $222M | $263M | $284M |
| Property, Plant & Equip. | $3M | $3M | $8M | $7M | $9M |
| Goodwill & Intangibles | $185K | $185K | $185K | $185K | $185K |
| Long-Term Investments | -$482K | -$1M | $134K | $213K | $0 |
| Other Non-Current Assets | $482K | $1M | $1M | $0 | $217K |
| Total Non-Current Assets | $3M | $4M | $9M | $9M | $12M |
| Total Assets | $144M | $194M | $231M | $272M | $296M |
| — Liabilities — | |||||
| Accounts Payable | $259K | $3M | $2M | $3M | $1M |
| Short-Term Debt | $0 | $0 | $0 | $0 | $388K |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $10M | $18M | $18M | $17M | $8M |
| Total Current Liabilities | $14M | $25M | $25M | $27M | $19M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $102K | $131K | $164K | $213K | $256K |
| Total Non-Current Liabilities | $5M | $4M | $3M | $4M | $4M |
| Total Liabilities | $18M | $29M | $28M | $31M | $23M |
| — Equity — | |||||
| Common Stock | $152M | $152M | $169M | $169M | $172M |
| Retained Earnings | -$38M | -$10M | $30M | $64M | $95M |
| Accumulated OCI | $12M | $23M | $4M | $8M | $6M |
| Total Stockholders Equity | $126M | $165M | $203M | $241M | $272M |
| Total Liabilities & Equity | $144M | $194M | $231M | $272M | $296M |
| — Key Metrics — | |||||
| Total Debt | $1M | $1000K | $880K | $529K | $2M |
| Net Debt | -$120M | -$156M | -$183M | -$224M | -$18M |
| Total Investments | $94M | $132M | $134K | $213K | $231M |